Key result
APACHE IVa provides superior hospital mortality discrimination compared to MPM0-III.
Why the study?
Does the APACHE IVa model improve hospital mortality prediction accuracy compared to MPM0-III and IOM/NQF models in ICU patients?
Observational (n=55,304)
Yes
Does the APACHE IVa model improve hospital mortality prediction accuracy compared to MPM0-III and IOM/NQF models in ICU patients?
The APACHE IVa model offers superior discrimination and calibration for predicting hospital mortality in ICU patients compared to the MPM0-III and IOM/NQF models.
APACHE IVa may outperform MPM-III and IOM/NQF for ICU mortality benchmarking; leaves open optimal model choice pending prospective validation.
OBJECTIVE: To examine the accuracy of the original Mortality Probability Admission Model III, ICU Outcomes Model/National Quality Forum modification of Mortality Probability Admission Model III, and Acute Physiology and Chronic Health Evaluation IVa models for comparing observed and risk-adjusted hospital mortality predictions. DESIGN: Retrospective paired analyses of day 1 hospital mortality predictions using three prognostic models. SETTING: Fifty-five ICUs at 38 U.S. hospitals from January 2008 to December 2012. PATIENTS: Among 174,001 intensive care admissions, 109,926 met model inclusion criteria and 55,304 had data for mortality prediction using all three models. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: We compared patient exclusions and the discrimination, calibration, and accuracy for each model. Acute Physiology and Chronic Health Evaluation IVa excluded 10.7% of all patients, ICU Outcomes Model/National Quality Forum 20.1%, and Mortality Probability Admission Model III 24.1%. Discrimination of Acute Physiology and Chronic Health Evaluation IVa was superior with area under receiver operating curve (0.88) compared with Mortality Probability Admission Model III (0.81) and ICU Outcomes Model/National Quality Forum (0.80). Acute Physiology and Chronic Health Evaluation IVa was better calibrated (lowest Hosmer-Lemeshow statistic). The accuracy of Acute Physiology and Chronic Health Evaluation IVa was superior (adjusted Brier score = 31.0%) to that for Mortality Probability Admission Model III (16.1%) and ICU Outcomes Model/National Quality Forum (17.8%). Compared with observed mortality, Acute Physiology and Chronic Health Evaluation IVa overpredicted mortality by 1.5% and Mortality Probability Admission Model III by 3.1%; ICU Outcomes Model/National Quality Forum underpredicted mortality by 1.2%. Calibration curves showed that Acute Physiology and Chronic Health Evaluation performed well over the entire risk range, unlike the Mortality Probability Admission Model and ICU Outcomes Model/National Quality Forum models. Acute Physiology and Chronic Health Evaluation IVa had better accuracy within patient subgroups and for specific admission diagnoses. CONCLUSIONS: Acute Physiology and Chronic Health Evaluation IVa offered the best discrimination and calibration on a large common dataset and excluded fewer patients than Mortality Probability Admission Model III or ICU Outcomes Model/National Quality Forum. The choice of ICU performance benchmarks should be based on a comparison of model accuracy using data for identical patients.
No takes yet. Share an insight, caveat, or question.
Kramer et al. (2013) conducted an observational in Intensive care admissions (n=55,304). Acute Physiology and Chronic Health Evaluation IVa model vs. Mortality Probability Admission Model III and ICU Outcomes Model/National Quality Forum was evaluated on Discrimination, calibration, and accuracy of hospital mortality predictions. The Acute Physiology and Chronic Health Evaluation IVa model provided superior discrimination (AUC 0.88) for hospital mortality compared with the Mortality Probability Admission Model III (AUC 0.81).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: